These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29117285)

  • 21. Radiation recall myelitis following capecitabine: First case report.
    Guerreiro C; Albuquerque L; Reimão S
    Clin Neurol Neurosurg; 2020 Sep; 196():105978. PubMed ID: 32540712
    [No Abstract]   [Full Text] [Related]  

  • 22. Pyogenic granuloma possibly associated with capecitabine therapy.
    Fujiwara C; Motegi SI; Sekiguchi A; Amano H; Ishikawa O
    J Dermatol; 2017 Nov; 44(11):1329-1331. PubMed ID: 27864844
    [No Abstract]   [Full Text] [Related]  

  • 23. Permanent lesion to the corticospinal tract after therapy with capecitabine.
    Wagner-Altendorf TA; Heldmann M; Hanssen H; Münte TF
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31537598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of exome sequencing to determine the full profile of genetic variants in the fluoropyrimidine pathway in colorectal cancer patients affected by severe toxicity.
    Pellicer M; García-González X; García MI; Blanco C; García-Alfonso P; Robles L; Grávalos C; Rueda D; Martínez J; Pachón V; Longo F; Martínez V; Iglesias I; Salvador S; Sanjurjo M; López-Fernández LA
    Pharmacogenomics; 2017 Aug; 18(13):1215-1223. PubMed ID: 28745575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative Capecitabine with Concurrent Intensity-Modulated Radiotherapy or Three-Dimensional Conformal Radiotherapy for Patients with Stage II and III Rectal Cancer.
    Lu NN; Jin J; Wang SL; Wang WH; Song YW; Liu YP; Ren H; Fang H; Liu XF; Yu ZH; Li YX
    PLoS One; 2015; 10(4):e0124601. PubMed ID: 25915948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiolymphoid hyperplasia with eosinophilia successfully treated with imiquimod. A case report.
    Gencoglan G; Karaca S; Ertekin B
    Dermatology; 2007; 215(3):233-5. PubMed ID: 17823521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia.
    Eames T; Grabein B; Kroth J; Wollenberg A
    J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):958-60. PubMed ID: 20015177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudopyogenic granuloma: effects of corticosteroid on newly-formed vessels.
    Kimura S
    J Dermatol; 1980 Feb; 7(1):29-35. PubMed ID: 15462073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A multicenter clinical study for the comparison of S-1 versus capecitabine in the treatment of advanced breast cancer].
    Li Y; Jiang D; Wu YY; Li LL; Cui YZ; Dong Q
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):607-612. PubMed ID: 28835084
    [No Abstract]   [Full Text] [Related]  

  • 30. A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.
    Capriotti KD; Anadkat M; Choi J; Kaffenberger B; McLellan B; Barone S; Kukoyi O; Goldfarb S; Lacouture M
    Invest New Drugs; 2019 Dec; 37(6):1247-1256. PubMed ID: 31240513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of new SNPs associated with severe toxicity to capecitabine.
    Pellicer M; García-González X; García MI; Robles L; Grávalos C; García-Alfonso P; Pachón V; Longo F; Martínez V; Blanco C; Iglesias I; Sanjurjo M; López-Fernández LA
    Pharmacol Res; 2017 Jun; 120():133-137. PubMed ID: 28347776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study.
    Harbeck N; Saupe S; Jäger E; Schmidt M; Kreienberg R; Müller L; Otremba BJ; Waldenmaier D; Dorn J; Warm M; Scholz M; Untch M; de Wit M; Barinoff J; Lück HJ; Harter P; Augustin D; Harnett P; Beckmann MW; Al-Batran SE;
    Breast Cancer Res Treat; 2017 Jan; 161(1):63-72. PubMed ID: 27798749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of Noninvasive Management With the Gutter Method for Epidermal Growth Factor Receptor Inhibitor-Induced Paronychia, Pyogenic Granuloma-Like Lesion, and Ingrown Nail.
    Agematsu A; Kamata M; Namiki K; Yabuuchi Y; Nagata M; Tada Y
    JAMA Dermatol; 2022 May; 158(5):583-585. PubMed ID: 35416917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of serum folate level with toxicity of capecitabine in patients with colorectal cancers: a prospective cohort study.
    Chan SL; Ma BB; Chan AK
    Hong Kong Med J; 2018 Jun; 24 Suppl 3(3):29-31. PubMed ID: 29937443
    [No Abstract]   [Full Text] [Related]  

  • 35. Doxycycline for the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab.
    Shu KY; Kindler HL; Medenica M; Lacouture M
    Br J Dermatol; 2006 Jan; 154(1):191-2. PubMed ID: 16403122
    [No Abstract]   [Full Text] [Related]  

  • 36. Possible Pathways of Capecitabine-Induced Hand-Foot Syndrome.
    Lou Y; Wang Q; Zheng J; Hu H; Liu L; Hong D; Zeng S
    Chem Res Toxicol; 2016 Oct; 29(10):1591-1601. PubMed ID: 27631426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients homozygous for DPYD c.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidines.
    Meulendijks D; Henricks LM; van Kuilenburg AB; Jacobs BA; Aliev A; Rozeman L; Meijer J; Beijnen JH; de Graaf H; Cats A; Schellens JH
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):875-80. PubMed ID: 27544765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of pharmacogenetics in capecitabine efficacy and toxicity.
    Lam SW; Guchelaar HJ; Boven E
    Cancer Treat Rev; 2016 Nov; 50():9-22. PubMed ID: 27569869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capecitabine-induced Leukoencephalopathy.
    Yoshimura K; Tokunaga S; Daga H; Inoue M
    Intern Med; 2019 Feb; 58(4):621-622. PubMed ID: 30333392
    [No Abstract]   [Full Text] [Related]  

  • 40. Better compliance with the guidelines on hand-foot syndrome in patients treated with capecitabine in colorectal and breast cancer as a result of nursing education.
    Krzemieniecki K; Zygulska AL; Kucharz J; Stokłosa
    Przegl Lek; 2016; 73(7):460-4. PubMed ID: 29676887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.